Scientific Advisory Board

After completion of his medical internship, he completed his MD degree in 1968 at the School of Medicine of the Paris University and obtained his certification in Hematology in 1970. He received his first nomination as Senior Lecturer in 1970 and became in 1974 Assistant Professor at Hopital Lariboisière (Prof. J. Caen). In 1979 he move to Mulhouse as Head of the Hematology Department and has been the founder and the Director of the “Institut de Recherche en Hématologie et Transplantation (IRHT) since 1987. His group was a pioneer in the field of peripheral blood stem cell (PBSC) and realized the 6^th worldwide PBSC graft in 1986. Since 2000  he is Professor and Director of the Educational Program on Hematopoiesis and Cellular Therapy at the University of Haute Alsace, Mulhouse, France. He is member of twelve national and international scientific and corresponding member of the New York Academy of Sciences. He was contributing to journal editorial boards like Bone Marrow, Stem cells or the Journal of Hematotherapy and European Editor for the Journal of Hematotherapy and Stem Cell Research . Since 1990, he has actively participated to scientific committees in International Meetings including 4 ISEH meetings. In July 2000 he was the laureate of the “Excellence Achievements Awards of the Millennium” in the field of Hematopoiesis. He had published more than 150 articles or book chapters focused on PBSC transplant and stem cells.

Professor of Hematology at the University Pierre & Marie Curie (UPMC) in Paris. Luc Douay is Director of the Biological Hematology Center at Trousseau Hospital (Paris).He was Scientific & Medical Director of the French Blood Agency. He is Expert at the French Biomedicine Agency and Scientific Director for the Cell Therapy Center in Ile-de-France.

Prof Luc Douay is a pioneer in the stem cell research and internationally known for his expertise in ex vivo expansion of stem cells. Since 2007, he is also Director of the INSERM Research Unit S938 dedicated to the proliferation and differentiation of stem cells. His research team is composed of more than 35 MDs, PhDs, engineers and technicians located in the Research Centre St Antoine (Paris)

Since June 2009 , Prof. Nader Abraham is Professor & Chairman of Physiology and Pharmacology at the Toledo University College of Medicine (Ohio, US) and Adjunct Professor of Pharmacology/Medicine, New York Medical College (New York, US) after more than 13 years as Professor of Pharmacology and Director of Stem Cells & Gene Therapy, New York Medical College (New York, US).

His long standing research contributions are focused on vascular dysfunction  which are a prelude to cardiovascular diseases including hypertension, stroke and myocardial infarct and the use of cell therapy for disease prevention.

Emeritus Professor at the University of Paris-Sud and an internationally renowned heart surgeon.